Bone tissue decalcification set liquid and bone tissue decalcification method
By using a combination set solution of formic acid formaldehyde mixture, sodium sulfate and ethanol, bone tissue decalcification is solved, and the problems of long decalcification time and tissue integrity are achieved, rapid and effective decalcification effect is achieved, suitable for clinical and experimental needs, and In line with the concept of environmental protection and conservation.
Patent Information
- Application Number
- CN202411114371.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-08
AI Technical Summary
Existing bone tissue decalcification methods are difficult to protect tissue integrity while ensuring the decalcification effect. The decalcification time is long, which affects the pathological diagnosis efficiency and does not conform to the concept of environmental protection and saving.
Using a bone tissue decalcification set solution, including 16.5% formic acid and 2% formaldehyde formic acid formaldehyde mixture, 5% sodium sulfate solution and 70% ethanol solution, the decalcification time is significantly shortened by the steps of soaking and running water rinsing to ensure that Organizational integrity.
It achieves rapid and effective bone tissue decalcification, shortens the decalcification time, protects tissue integrity, is suitable for clinical and experimental pathological needs, and is in line with the concept of environmental protection and saving.
Smart Images

Figure CN118913839A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and more particularly to a bone tissue decalcification solution and a bone tissue decalcification method. Background Art
[0002] In experimental pathological research or clinical pathology, histopathological observations are often performed on animal or human bone tissue, but it contains a large amount of calcium tissue and is very hard. It needs to be decalcified before slice preparation. Decalcification is an important part of tissue sectioning. When decalcifying different bone tissues, it is necessary to take into account both sufficient decalcification and tissue integrity. Insufficient decalcification and excessive decalcification will have an adverse effect on pathological diagnosis. Insufficient decalcification will cause damage to the slice blade and tissue detachment. Excessive decalcification will destroy the tissue structure, affect the staining effect or cause the loss of tissue antigens, and affect the results of pathological diagnosis. Therefore, it is particularly important to study and select a suitable decalcification method to ensure the decalcification effect without affecting the subsequent HE staining, special staining and immunohistochemical staining for the pathological diagnosis of bone tissue.
[0003] Current bone tissue decalcification solutions mainly include EDTA decalcification solution, nitrate formaldehyde decalcification solution, hydrochloric acid formaldehyde decalcification solution, etc. However, although the EDTA decalcification method has little effect on tissue structure, the decalcification time is slow, and it takes several weeks for large bone tissues, which cannot meet the clinical and experimental animal cycle requirements. The hydrochloric acid / nitrate formaldehyde decalcification method can remove a large amount of calcium in a short time, but it is highly destructive to tissue morphology and cannot be used for immunohistochemical staining. After decalcification, it needs to be rinsed with running water for a long time (12-24 hours) to reduce strong acid reagents, which is not in line with environmental protection and conservation concepts.
[0004] Therefore, it is an urgent problem for technicians in this field to provide a bone tissue decalcification product or method that takes into account both decalcification performance and tissue integrity while embodying the concept of green and economical. Summary of the invention
[0005] In view of this, the present invention provides a bone tissue decalcification solution and a bone tissue decalcification method.
[0006] In order to achieve the above object, the present invention adopts the following technical solution:
[0007] A bone tissue decalcification method comprises the following steps: immersing the fixed bone tissue in a bone tissue decalcification kit solution a, and after the syringe needle is inserted without resistance, trimming the bone tissue into a tissue block of appropriate size and uniform thickness according to the different bone tissue morphologies, and placing the block in a dehydration box; placing the dehydration box containing the tissue block in solution b for 2 to 12 hours, then transferring it to solution c for immersion for 2 to 4 hours, and then rinsing it with running water for 0.5 to 4 hours;
[0008] Among them, liquid a is a formic acid-formaldehyde mixture containing 16.5% formic acid and 2% formaldehyde; liquid b is a 5% sodium sulfate solution; and liquid c is a 70% ethanol solution.
[0009] Preferably, the dehydration box containing the tissue blocks is immersed in liquid B for 2 hours.
[0010] Preferably, the dehydration box containing the tissue blocks is immersed in liquid C for 2 hours.
[0011] Preferably, the flushing time with running water is 0.5 hours.
[0012] Another object of the present invention is to provide a bone tissue decalcification package solution, which consists of solution A, solution B and solution C; wherein solution A is a formic acid-formaldehyde mixed solution containing 16.5% formic acid and 2% formaldehyde; solution B is a 5% sodium sulfate solution; and solution C is a 70% ethanol solution.
[0013] Another object of the present invention is to provide a method for preparing the above-mentioned bone tissue decalcification solution, wherein the a solution is obtained by mixing 33% formic acid solution and 4% formaldehyde solution in a volume ratio of 1:1; the b solution is obtained by diluting sodium sulfate with purified water in proportion; and the c solution is obtained by diluting anhydrous ethanol with purified water.
[0014] Beneficial effects: The bone tissue decalcification package and decalcification method of the present invention have good decalcification effect, and the bone tissue integrity is good after decalcification, which meets the observation requirements, and significantly shortens the decalcification time, which is conducive to the rapid judgment of clinical and experimental pathological test results. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.
[0016] Figure 1 These are the staining results of SD rat skull tissue using different decalcification methods in Example 1, wherein the first row is the HE staining results (100X, A1, B1, C1, method A, method B, method C, respectively), the second row is the Masson staining results (100X, A2, B2, C2, method A, method B, method C, respectively), and the third row is the immunohistochemical staining results (200X, A3, B3, C3, method A, method B, method C, respectively).
[0017] Figure 2These are the staining results of femoral tissue of SD rats using different decalcification methods in Example 2, wherein the first row is the HE staining results (100X, A1, B1, C1, method A, method B, method C, respectively), the second row is the Safranin O-Fast Green staining results (100X, A2, B2, C2, method A, method B, method C, respectively), and the third row is the immunohistochemical staining results (200X, A3, B3, C3, method A, method B, method C, respectively).
[0018] Figure 3 These are the staining results of SD rat tibia tissues treated with the decalcification solution for different treatment times in Example 3, wherein the first row is the HE staining results (100X, methods ①-④ in sequence), and the second row is the HE staining results (100X, methods ⑤-⑧ in sequence). DETAILED DESCRIPTION
[0019] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0020] Example 1
[0021] 1. Experimental materials: SD rats were purchased from Beijing Huafukang Biotechnology Co., Ltd. After the routine experimental process, they were anesthetized and dissected, and the skull tissues were cut and fixed in 10% formalin fixative for 48 hours.
[0022] 2. Decalcification: Soak the fixed skull in liquid a of the bone tissue decalcification kit at room temperature. When the syringe needle is inserted without resistance, decalcification is completed. Trim the skull tissue into a tissue block of appropriate size and uniform thickness. In this example, the tissue block is about 1.0cm×0.5cm×0.3cm and place it in a dehydration box; soak the dehydration box containing the tissue block in liquid b for 2 hours, then transfer it to liquid c and soak it for another 2 hours, and then rinse it with running water for 0.5 hours.
[0023] Among them, liquid a is a formic acid and formaldehyde mixture; liquid b is a 5% sodium sulfate solution; and liquid c is a 70% ethanol solution.
[0024] Preparation method of liquid a, liquid b and liquid c: Mix 33% formic acid solution and 4% formaldehyde solution in a volume ratio of 1:1 to obtain liquid a. Take 50 grams of anhydrous sodium sulfate powder and add 950 milliliters of pure water, stir evenly, and dilute to 1000 milliliters with pure water to obtain a sodium sulfate solution with a mass fraction of 5%, which is liquid b. Take 700 milliliters of anhydrous ethanol, add pure water to dilute to 1000 milliliters, and mix to obtain an ethanol solution with a volume fraction of 70%, which is liquid c.
[0025] The above decalcification method is called method A, and method B and method C are used as controls. The methods are as follows: Method B--Place the fixed skull in a hydrochloric acid formaldehyde mixture (100 mL of 4% formaldehyde, 50 mL of concentrated hydrochloric acid, and pure water to 1000 mL) for decalcification at room temperature. After the syringe needle is inserted without resistance, trim the skull tissue into a tissue block of appropriate size and uniform thickness. The tissue block in this example is approximately 1.0 cm×0.5 cm×0.3 cm, and place it in a dehydration box and rinse with running water for 6 hours. Method C: Place the fixed skull in 10% EDTA decalcification solution (EDTA 100g dissolved in phosphate buffer (PBS) or Tris buffer (PH6.8-7.0) 1000ml) at room temperature for decalcification. After the syringe needle can be inserted without resistance, trim the skull tissue into a tissue block of appropriate size and uniform thickness. The tissue block in this example is approximately 1.0cm×0.5cm×0.3cm, and place it in a dehydration box and rinse with running water for 6 hours.
[0026] 3. Post-decalcification treatment: Use Leica ASP200S fully automatic tissue dehydrator for dehydration, transparency and wax impregnation. Use Leica EG1150H tissue embedding machine for embedding. Use Leica RM2255 fully automatic slicer for slicing, with a slice thickness of 3μm.
[0027] 4. Slice staining and effect observation: HE staining, Masson staining and immunohistochemical staining were performed on the slices obtained in step 3 to observe the decalcification and staining effects of bone tissue.
[0028] HE staining steps: the sections were dewaxed with xylene, hydrated with gradient ethanol, stained with hematoxylin for 4 minutes, differentiated with hydrochloric acid and ethanol, blued with ammonia, stained with eosin for 1 minute, dehydrated with gradient ethanol, transparentized with xylene, and sealed with neutral resin.
[0029] Masson staining steps: sections were dewaxed into distilled water, stained with hematoxylin for 2 min, washed with distilled water, stained in ponceau acid fuchsin solution for 5 min, washed with water, then stained in 1% phosphomolybdic acid for 5 min, directly immersed in aniline blue solution for 5 min, differentiated with hydrochloric acid and ethanol, dehydrated with gradient ethanol, transparentized with xylene, and sealed with neutral gum.
[0030] Immunohistochemical staining steps: observe the expression of collagen II in skull tissue. Conventional paraffin sections are dewaxed to water; 3% H 2 O 2Block endogenous peroxidase at room temperature for 10 minutes; repair antigens by microwave heating; block with 5% BSA for 20 minutes; add collagen II primary antibody at 4°C overnight; add goat anti-rabbit IgG antibody after PBS washing and incubate at 37°C for 20 minutes; develop color with DAB after PBS washing; counterstain with hematoxylin, dehydrate with ethanol, make transparent with xylene, and seal with neutral gum.
[0031] 5. Results
[0032] (1) Comparison of decalcification time: Method B (about 6 hours) < Method A (about 12 hours) <
[0033] Method C (about 60 hours): the decalcification time of the decalcification solution method of the present invention is 12 hours, which significantly shortens the sample detection time.
[0034] (2) Observation of decalcification effect: Figure 1 As shown in the figure, the HE staining results of methods A and C showed that the bone tissue structure was intact, the morphology was normal, the staining was uniform, the cell nucleus was blue and clear, and the cytoplasm was bright; Masson staining showed that mature osteocytes were red and the bone matrix was blue, which could clearly distinguish the different structures of bone tissue; immunohistochemical staining showed that collagen II in osteocytes was strongly expressed and clearly positioned. However, the HE staining of method B was uneven, with excessive red staining in some areas, cracks in the peripheral tissue, and damaged tissue integrity; Masson staining was lighter, with wrinkles in some areas; immunohistochemical staining showed that collagen II in osteocytes was weakly expressed, lightly stained, and unclearly positioned.
[0035] The above results show that the decalcification effect of the decalcification solution and decalcification method of the present invention meets tissue integrity, and the time is significantly shorter than that of the EDTA method, which is beneficial to clinical and experimental needs.
[0036] Example 2
[0037] 1. Experimental materials: SD rats were purchased from Beijing Huafukang Biotechnology Co., Ltd. After the routine experimental process, they were anesthetized and dissected, and the femoral tissues were cut and fixed in 10% formalin fixative for 96 hours.
[0038] 2. Decalcification: Soak the fixed femur in liquid a of the bone tissue decalcification kit at room temperature. After the syringe needle is inserted without resistance, trim the femoral tissue into a tissue block of appropriate size and uniform thickness. In this example, the tissue block is about 1.0 cm × 1.0 cm × 0.3 cm and place it in a dehydration box; soak the dehydration box containing the tissue block in liquid b for 2 hours, then transfer it to liquid c and soak it for another 2 hours, and then rinse it with running water for 0.5 hour.
[0039] The components and preparation methods of liquid a, liquid b and liquid c are the same as those in Example 1.
[0040] The above decalcification treatment method is called method A, and method B and method C are used as controls. The methods are as follows: Method B--Place the fixed femur in 5% hydrochloric acid formaldehyde for decalcification at room temperature. After the syringe needle is inserted without resistance, trim the femoral tissue into a tissue block of appropriate size and uniform thickness. The tissue block in this example is about 1.0cm×1.0cm×0.3cm, and place it in a dehydration box for 6 hours. Method C--Place the fixed femur in 10% EDTA decalcification solution for decalcification at room temperature. After the syringe needle is inserted without resistance, trim the skull tissue into a tissue block of appropriate size and uniform thickness. The tissue block in this example is about 1.0cm×1.0cm×0.3cm, and place it in a dehydration box for 6 hours.
[0041] 3. Post-decalcification treatment: Use Leica ASP200S fully automatic tissue dehydrator for dehydration, transparency and wax impregnation. Use Leica EG1150H tissue embedding machine for embedding. Use Leica RM2255 fully automatic slicer for slicing, with a slice thickness of 3μm.
[0042] 4. Slice staining and effect observation: The slices obtained in step 3 were subjected to HE staining, Safranin O-fast green staining and immunohistochemical staining to observe the decalcification and staining effects.
[0043] HE staining steps: the sections were dewaxed with xylene, hydrated with gradient ethanol, stained with hematoxylin for 4 minutes, differentiated with hydrochloric acid and ethanol, blued with ammonia, stained with eosin for 1 minute, dehydrated with gradient ethanol, transparentized with xylene, and sealed with neutral resin.
[0044] Safranin O-Fast Green staining steps: the sections were routinely dewaxed, stained in freshly prepared Weigert stain for 3 minutes, and washed with water; differentiated in acidic differentiation solution for 15 seconds, washed with distilled water for 10 minutes; immersed in Fast Green staining solution for 5 minutes; washed with weak acid solution for 10 seconds to remove residual Fast Green; immersed in Safranin O for 5 minutes; dehydrated with 95% ethanol and anhydrous ethanol respectively; transparentized with xylene and sealed with neutral resin.
[0045] Immunohistochemical staining steps: observe the expression of RUNX2 in femoral tissue. Conventional paraffin sections were dewaxed to water; 3% H2O2 was used at room temperature for 10 minutes to block endogenous peroxidase; microwave heating was used to repair antigens; 5% BSA was blocked for 20 minutes; RUNX2 primary antibody was added dropwise at 4°C overnight; goat anti-rabbit IgG antibody was added after PBS washing, and incubated at 37°C for 20 minutes; DAB was used for color development after PBS washing; hematoxylin counterstaining, ethanol dehydration, xylene transparent, and neutral gum sealing.
[0046] 5. Results
[0047] (1) Comparison of decalcification time: Method B (about 48 hours) < Method A (about 72 hours) <
[0048] Method C (about 360 hours): the decalcification time of the decalcification solution method of the present invention is 72 hours, which significantly shortens the sample detection time.
[0049] (2) Observation of decalcification effect: Figure 2 As shown,
[0050] HE staining of methods A and C showed that the femoral tissue structure was intact, the morphology was normal, the cells in each layer were arranged in an orderly manner, the staining was uniform, the cell nucleus was blue and clear, and the cytoplasm was bright; Safranin O-fast green staining showed that chondrocytes were red and osteocytes were blue, which could clearly distinguish cartilage and bone tissue; immunohistochemical staining showed strong expression of RUNX2 in chondrocytes and obvious localization. HE staining of method B showed obvious wrinkles in the tissue, which affected the observation; Safranin O-fast green staining was darker and had wrinkles in some parts; immunohistochemical staining showed that the expression and localization of RUNX2 in osteocytes were not obvious, the tissue was incomplete, and there were obvious cracks.
[0051] The above results show that the decalcification effect of the decalcification solution and decalcification method of the present invention meets tissue integrity, and the time is significantly shorter than that of the EDTA method, which is beneficial to clinical and experimental needs.
[0052] Example 3
[0053] 1. Experimental materials: SD rats were purchased from Beijing Huafukang Biotechnology Co., Ltd. After the routine experimental process, they were anesthetized and dissected, and the tibia tissue was cut and fixed in 10% formalin fixative for 96 hours.
[0054] 2. Decalcification: Immerse the fixed tibia in the bone tissue decalcification solution a at room temperature. After the syringe needle is inserted without resistance, trim the tibia tissue into a tissue block of appropriate size and uniform thickness. In this example, the tissue block is about 1.0 cm × 0.6 cm × 0.3 cm and placed in a dehydration box. Subsequently, the tissue blocks are divided into 8 groups according to the different flushing treatment times of solution b and solution c, as shown in Table 1:
[0055]
[0056]
[0057] The components and preparation methods of liquid a, liquid b and liquid c are the same as those of Examples 1 and 2.
[0058] 3. Post-decalcification treatment: Use Leica ASP200S fully automatic tissue dehydrator for dehydration, transparency and wax impregnation. Use Leica EG1150H tissue embedding machine for embedding. Use Leica RM2255 fully automatic slicer for slicing, with a slice thickness of 3μm.
[0059] 4. Slice staining and effect observation: HE staining was performed on the slices obtained in step 3 to observe the staining effects of different treatment times.
[0060] HE staining steps: the sections were dewaxed with xylene, hydrated with gradient ethanol, stained with hematoxylin for 4 minutes, differentiated with hydrochloric acid and ethanol, blued with ammonia, stained with eosin for 1 minute, dehydrated with gradient ethanol, transparentized with xylene, and sealed with neutral resin.
[0061] 5. Results
[0062] Dyeing effect observation: as attached Figure 3 As shown, the tibia tissues in groups ①-⑧ were intact in structure, normal in morphology, uniformly stained, with blue and clear nuclei and bright cytoplasm; the results showed that after decalcification in solution a, subsequent immersion in solution b for 2 to 12 hours, in solution c for 2 to 4 hours, and rinsing in running water for 0.5 to 4 hours had no significant effect on the soft color results of bone tissue. In line with the principles of improving experimental efficiency and saving resources, the optimal choice was immersion in solution b for 2 hours, immersion in solution c for 2 hours, and rinsing in running water for 0.5 hours.
[0063] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.
[0064] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for decalcifying bone tissue, characterized in that: The following steps are involved: The fixed bone tissue is immersed in the bone tissue decalcification set liquid a, and after the syringe needle is inserted without resistance, the bone tissue is trimmed into a tissue block of appropriate size and uniform thickness according to the different morphologies of the bone tissue, and placed in a dehydration box; Place the dehydration box containing the tissue block in solution B for 2 to 12 hours, then transfer it to solution C for 2 to 4 hours, and then rinse with running water for 0.5 to 4 hours; Among them, liquid a is a formic acid-formaldehyde mixture containing 16.5% formic acid and 2% formaldehyde; liquid b is a 5% sodium sulfate solution; and liquid c is a 70% ethanol solution.
2. The method for decalcifying bone tissue according to claim 1, characterized in that: The dehydration box containing the tissue block is immersed in liquid B for 2 hours.
3. The bone tissue decalcification method according to claim 1, characterized in that: The dehydration box containing the tissue block is immersed in liquid C for 2 hours.
4. The method for decalcifying bone tissue according to claim 1, characterized in that: The time of the running water flushing is 0.5 hours.
5. A bone tissue decalcification solution, characterized in that: The package liquid consists of liquid A, liquid B and liquid C; wherein liquid A is a formic acid-formaldehyde mixed liquid containing 16.5% formic acid and 2% formaldehyde; liquid B is a 5% sodium sulfate solution; and liquid C is a 70% ethanol solution.
6. The method for preparing the bone tissue decalcification solution according to claim 5, characterized in that: The liquid A is obtained by mixing 33% formic acid solution and 4% formaldehyde solution in a volume ratio of 1:1; the liquid B is obtained by diluting sodium sulfate with purified water in a certain proportion; and the liquid C is obtained by diluting anhydrous ethanol with purified water.
